Nubia Muñoz

Nubia Muñoz

Auto-generated profile, based on publicly available information

Nubia Muñoz

Unit of Field and Intervention Studies, International Agency for Research on Cancer, Lyon, France

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in The Lancet
Verified
Journal Article
Closed access
NMNubia Muñoz
Nubia Muñoz
SFSilvia Franceschi
Silvia Franceschi
Cristina BosettiCristina Bosetti
Cristina Bosetti
VMVictor Moreno
Victor Moreno
RHRolando Herrero
Rolando Herrero
IGInternational Agency for Research on Cancer. Multicentric Cervical Cancer Study Group
International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group

7 January 1998 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
CNC Ngelangel
C Ngelangel
NMN Muñoz
N Muñoz
FBF X Bosch
F X Bosch
GLG M Limson
G M Limson
MFM R Festin
M R Festin
JWJ M Walboomers
J M Walboomers
Background: Among the numerous human papillomavirus (HPV) types, only types 16 and 18 have been formally classified as human carcinogens. To evaluate the associations of 33 HPV types and other risk factors with squamous cell carcinoma and adenocarcinoma of the cervix, we performed a hospital-based, case-control study in the Philippines. Methods: The study included 356 case subjects who had histologically confirmed cervical cancer (323 incident cases of squamous cell carcinoma and 33 incident cases of adenocarcinomacarcinoma) and 381 control subjects. Information on risk factors was obtained by personal interview. HPV DNA was detected in exfoliated cervical cells and biopsy specimens by use of a polymerase chain reaction assay. Results: HPV DNA was detected in 93.8% of case subjects with squamous cell carcinoma and in 90.9% of case subjects with adenocarcinomacarcinoma compared with 9.2% of control subjects, giving age-adjusted odds ratios of 156 (95% confidence interval [CI] = 87-280) for squamous cell carci noma and 111 (95% CI = 31-392) for adenocarcinomacar cinoma. Fifteen different HPV types were detected in squamous cell carci noma, and six different HPV types were detected in adenocarcinoma adenosquamous carcinoma. Among HPV types other than types 16 and 18, the associations of HPV with risk of squamous cell carcinoma were strong est for HPV45. In addition to HPV, high parity, low socioeconomic status, and smoking were also associated with both types of cervical cancer. Conclusions: As has been shown for squamous cell carcinoma, HPV is the central cause of adenocarcinoma mous carcinoma of the uterine cervix. The observed associations of less preva lent HPV types with cervical cancer have important implications for cervi cal cancer prevention strategies. [J Natl Cancer Inst 1998;90:43-9]

15 February 2000 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
PRPedro A. Rolón
Pedro A. Rolón
JSJennifer S. Smith
Jennifer S. Smith
NMNubia Muñoz
Nubia Muñoz
SKStefanie J. Klug
Stefanie J. Klug
RHRolando Herrero
Rolando Herrero
JWJan M.M. Walboomers
Jan M.M. Walboomers
HPV types 16 and 18 have been categorized as human carcinogens based on their strong associations with cervical cancer in previous case‐control studies. Recent IARC studies in the Philippines, Thailand and Morocco show strong associations between invasive cervical cancer and less common HPV types, including HPV 31, 33, 45, 51, 52 and 58. We present results of a further IARC case‐control study conducted in Asunción, Paraguay, to examine the association between specific HPV types and invasive cervical cancer as well as risk factors other than HPV. One‐hundred thirteen incident histologically confirmed invasive cervical cancer cases and 91 age‐matched hospital controls were recruited. A standardized questionnaire was administered to investigate known and suspected risk factors for cervical cancer. For HPV status determination, cervical biopsy specimens from case subjects and exfoliated cervical cells from control subjects were obtained. HPV DNA was ascertained using a GP5+/6+ PCR‐based assay capable of detecting more than 33 HPV types. Overall HPV prevalence was 97% in the cervical cancer cases and 20% in the control subjects. As a single infection, HPV 16 was the predominant type with a prevalence of 48% among case subjects and 5.5% among control subjects. Significant associations with the risk of cervical cancer were detected as follows: any HPV type (OR = 114; 95% CI: 36–361); HPV 16 (OR = 910); HPV 18 (infinite OR); HPV 31 (OR = 110); HPV 33 (OR = 261); HPV 45 (OR = 129); and HPV 58 (OR = 36). In the multivariate model, risk factors other than HPV significantly associated with cervical cancer risk were a higher number of lifetime sexual partners, lower educational status and never having had a Pap smear. Strong associations were found between invasive cervical cancer and specific HPV types 16, 18, 31, 33, 45 and 58. Int. J. Cancer 85:486–491, 2000.

22 September 2009 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Closed access
PDF file
NMN. Muñoz
N. Muñoz
Cáncer gástrico y Helicobacter pylori: evidencia epidemiológica y perspectivas para la prevención